PREMARKET ALERT: Amgen (AMGN)

Posted in General 
July 28th, 2009

Amgen Inc. (Nasdaq: AMGN) shares  fell about 1 percent to $60.33 after hours on Monday with more than 2.3 million shares traded after hours, making it one of the most active Nasdaq stocks. The company posted better-than-expected top and bottom-line result but had disappointing sales of its blockbuster Neulasta. -

UPDATE:   Stock is up 2.7 percent to $62.42 in premarket volume of about 130,000 shares as of 9 a.m. Eastern.  — Mike Tarsala
See full story at BioHealthInvestor.com

Comments are closed

-->